Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
Phase 4
Withdrawn
- Conditions
- Abdominal Cutaneous Nerve Entrapment SyndromeChronic Abdominal Wall Pain
- Interventions
- Registration Number
- NCT02748395
- Lead Sponsor
- Temple University
- Brief Summary
The purpose of this study is to determine whether the injection of triamcinolone and lidocaine is effective in relieving chronic abdominal wall pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Clinical diagnosis of chronic abdominal wall pain
- Prior ultrasound or cross-sectional imaging of the abdomen to exclude other causes
- Baseline Brief Pain Inventory score ≥ 5
Exclusion Criteria
- Multiple trigger points
- Abdominal wall hernia on exam
- Weight loss
- Rectal bleeding
- Recent change in bowel habits
- Decompensated cirrhosis or recurrent ascites
- Allergy or contraindication to study medications
- Known thrombocytopenia with platelet count < 50,000
- Other diagnosis of chronic pain syndromes including fibromyalgia
- Unable to provide informed consent
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Placebo Placebo Injection of 3.5mL of normal saline into the point of maximal tenderness in the abdomen Treatment Triamcinolone Injection of 20mg triamcinolone and 1% lidocaine into the point of maximal tenderness in the abdomen Treatment Lidocaine Injection of 20mg triamcinolone and 1% lidocaine into the point of maximal tenderness in the abdomen
- Primary Outcome Measures
Name Time Method Pain score Baseline and 1 month Questionnaire to assess change in pain score
- Secondary Outcome Measures
Name Time Method Pain score Baseline and 2 months Questionnaire to assess change in pain score